Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-020087
Filing Date
2023-05-10
Accepted
2023-05-10 07:31:05
Documents
48
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q tcrx-20230331.htm   iXBRL 10-Q 2153247
2 EX-31.1 tcrx-ex31_1.htm EX-31 29262
3 EX-31.2 tcrx-ex31_2.htm EX-31 29526
4 EX-32.1 tcrx-ex32_1.htm EX-32 11772
5 EX-32.2 tcrx-ex32_2.htm EX-32 11683
  Complete submission text file 0000950170-23-020087.txt   5664640

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT tcrx-20230331_cal.xml EX-101.CAL 31334
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tcrx-20230331_pre.xml EX-101.PRE 275424
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tcrx-20230331.xsd EX-101.SCH 39820
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tcrx-20230331_lab.xml EX-101.LAB 362959
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT tcrx-20230331_def.xml EX-101.DEF 186380
42 EXTRACTED XBRL INSTANCE DOCUMENT tcrx-20230331_htm.xml XML 545543
Mailing Address 880 WINTER STREET WALTHAM MA 02451
Business Address 880 WINTER STREET WALTHAM MA 02451 857-399-9500
TScan Therapeutics, Inc. (Filer) CIK: 0001783328 (see all company filings)

EIN.: 825282075 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40603 | Film No.: 23904347
SIC: 2836 Biological Products, (No Diagnostic Substances)